VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.

17:51 26/11/2025

Vicon Holdings (03878) has released its interim results for the six months ended September 30, 2025. The group achieved a profit of HK$119 million, a decrease of 28.21% year-on-year; the attributable profit to shareholders is HK$5.566 million, a decrease of 13.3% year-on-year; and earnings per share is 1.16 HK cents.

VICON HOLDINGS (03878) released its interim performance for the six months ended September 30, 2025. The group gained a revenue of HK$119 million, a decrease of 28.21% compared to the same period last year. The company's attributable profit was HK$5.566 million, a decrease of 13.3% year-on-year. Basic earnings per share were 1.16 HK cents. The announcement stated that the decrease in revenue was mainly due to several projects with relatively high contract amounts being completed in the previous period, and the projects contributing revenue in this period having lower contract amounts.

GUSHENGTANG (02273) repurchased 227,300 shares at a cost of HK$6,789,500 on November 26th.

SPRING REIT (01426) spent 48,800 Hong Kong dollars to repurchase 30,000 fund units on November 26th.

CONSUN PHARMA (01681) spent HKD 1.9573 million to repurchase 13.1 thousand shares on November 26th.

GUSHENGTANG (02273) repurchased 227,300 shares at a cost of HK$6,789,500 on November 26th.

SPRING REIT (01426) spent 48,800 Hong Kong dollars to repurchase 30,000 fund units on November 26th.

CONSUN PHARMA (01681) spent HKD 1.9573 million to repurchase 13.1 thousand shares on November 26th.